Long-form guides, side-effect deep-dives, and protocol comparisons for men’s health. No paid posts. No “transform your life” copy. We write what we’d want to read before making a treatment decision — for ourselves or someone in our family. Browse by category, search by keyword, or read everything we’ve published.
PT-141 (bremelanotide) is the only peptide with phase 3 randomized trial data and FDA approval in the sexual desire space — everything else researchers compare it against is operating on preclinical evidence or early human data at best.
Peptide therapy spans a wide price range — from roughly $100 per month for tissue-repair compounds to over $1,300 for brand-name GLP-1 weight-loss drugs like Wegovy.
For men over 40, three peptides dominate the research-grade sleep conversation: DSIP (emideltide), epitalon, and CJC-1295. Of the three, DSIP has the most direct human sleep data, CJC-1295 has the strongest pharmacokinetic profile, and epitalon is the most speculative — but all…
For a 42-year-old man dealing with creeping visceral fat, slower recovery, and flagging energy, the peptide market offers a dizzying menu — but the evidence narrows the useful options quickly.
BPC-157 carries the stronger and more internally consistent preclinical evidence base for musculoskeletal repair — more animal models, more tissue types, more mechanistic detail.
Inject sermorelin 30–60 minutes before sleep, in a fasted state. That single timing decision — aligning the peptide's brief stimulus with the body's largest nocturnal growth hormone pulse — accounts for most of what separates effective research protocols from wasted vials.
Ipamorelin produces a clean, discrete GH pulse per injection — no meaningful cortisol or prolactin bleed, just selective GHSR-1a activation. The standard effective range is 100–300 mcg per injection, one to three times daily, with the GH response plateauing around 300 mcg per…
The standard TB-500 research protocol runs 8–12 weeks total, divided into a higher-dose loading phase (4–6 weeks) and a reduced-frequency maintenance phase (4–6 weeks).
Animal research on thymosin beta-4 (Tβ4) — the parent molecule behind TB-500 — maps a consistent, tissue-dependent repair arc: measurable molecular activity within hours, functional gains by weeks two to four, and structural consolidation by weeks eight to twelve.
Ipamorelin triggers a sharp, selective GH pulse via the ghrelin receptor; sermorelin mimics endogenous GHRH to produce a more physiologic, feedback-regulated GH release.
Researchers working with BPC-157 typically use 250–500 mcg per day, administered subcutaneously, for cycles of four to eight weeks. The evidence base supporting that range is almost entirely preclinical — robust in rodent models, thin in humans — so every number here should be…
Ready to start a protocol?
Connect with vetted online providers for TRT, GLP-1, ED treatment, and more.
